Loss of the coxsackie and adenovirus receptor contributes to gastric cancer progression

British Journal of Cancer

Volumn 100, Issue 2, 2009, Pages 352-359

  Anders, M ^a   Vieth, M ^b   Rocken C ^a   Ebert, M ^c   Pross, M ^d   Gretschel, S ^e   Schlag, P M ^e   Wiedenmann, B ^a   Kemmner, W ^f   Hocker M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b INSTITUTE OF PATHOLOGY   (Germany)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d German Red Cross Hospital   (Germany)

^e Section of Pathology   (Germany)

^f MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Coxsackie adenovirus receptor; Gastric cancer; Invasion; Migration; Prognosis

Indexed keywords

COMPLEMENTARY DNA; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; SMALL INTERFERING RNA;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INFILTRATION; CANCER INVASION; CANCER SURVIVAL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY; RNA INTERFERENCE; STOMACH ADENOCARCINOMA; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH EPITHELIUM; STOMACH MUCOSA; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADENOVIRIDAE; ADULT; AGED; AGED, 80 AND OVER; BLOTTING, WESTERN; CELL MOVEMENT; CELL PROLIFERATION; ENTEROVIRUS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GASTRIC MUCOSA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROGNOSIS; RECEPTORS, VIRUS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STOMACH NEOPLASMS; TISSUE ARRAY ANALYSIS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 58749109933     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6604876     Document Type: Article

References (45)

1. Anders M, Christian C, McMahon M, McCormick F, Korn WM (2003a) Inhibition of the Raf/MEK/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells. Cancer Res 63: 2088-2095
2. Anders M, Hansen R, Ding RX, Rauen KA, Bissell MJ, Korn WM (2003b) Disruption of 3D tissue integrity facilitates adenovirus infection by deregulating the coxsackievirus and adenovirus receptor. Proc Natl Acad Sci USA 100: 1943-1948
3. Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL, Finberg RW (1997) Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275: 1320-1323
4. Bruning A, Runnebaum IB (2003) CAR is a cell-cell adhesion protein in human cancer cells and is expressionally modulated by dexamethasone, TNFalpha, and TGFbeta. Gene Therapy 10: 198-205
5. Bruning A, Runnebaum IB (2004) The coxsackie adenovirus receptor inhibits cancer cell migration. Exp Cell Res 298: 624-631
6. Buscarini M, Quek ML, Gilliam-Hegarich S, Kasahara N, Bochner B (2007) Adenoviral receptor expression of normal bladder and transitional cell carcinoma of the bladder. Urol Int 78: 160-166
7. Christofori G, Semb H (1999) The role of the cell-adhesion molecule E-cadherin as a tumour-suppressor gene. Trends Biochem Sci 24: 73-76
8. Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT, Bergelson JM (2001) The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci USA 98: 15191-15196
9. Coyne CB, Voelker T, Pichla SL, Bergelson JM (2004) The coxsackievirus and adenovirus receptor interacts with the multi-PDZ domain protein-1 (MUPP-1) within the tight junction. J Biol Chem 279: 48079-48084
10. Dhawan P, Singh AB, Deane NG, No Y, Shiou SR, Schmidt C, Neff J, Washington MK, Beauchamp RD (2005) Claudin-1 regulates cellular transformation and metastatic behavior in colon cancer. J Clin Invest 115: 1765-1776
11. Excoffon KJ, Hruska-Hageman A, Klotz M, Traver GL, Zabner J (2004) A role for the PDZ-binding domain of the coxsackie B virus and adenovirus receptor (CAR) in cell adhesion and growth. J Cell Sci 117: 4401-4409
12. Guilford P (1999) E-cadherin downregulation in cancer: fuel on the fire? Mol Med Today 5: 172-177
13. Hamilton SR, Aaltonen LA (eds) IPL2 (2000) WHO ClassificationTumours of the Digestive System Pathology & Genetics. IARC Press: Lyon
14. Heideman DA, Snijders PJ, Craanen ME, Bloemena E, Meijer CJ, Meuwissen SG, Van Beusechem VW, Pinedo HM, Curiel DT, Haisma HJ, Gerritsen WR (2001) Selective gene delivery toward gastric and esophageal adenocarcinoma cells via EpCAM-targeted adenoviral vectors. Cancer Gene Ther 8: 342-351
15. Hewitt KJ, Agarwal R, Morin PJ (2006) The claudin gene family: expression in normal and neoplastic tissues. BMC Cancer 6: 186
16. Hohenberger P, Gretschel S (2003) Gastric cancer. Lancet 362: 305-315
17. Huang KC, Altinoz M, Wosik K, Larochelle N, Koty Z, Zhu L, Holland PC, Nalbantoglu J (2005) Impact of the coxsackie and adenovirus receptor (CAR) on glioma cell growth and invasion: requirement for the C-terminal domain. Int J Cancer 113: 738-745
18. Huang KC, Yasruel Z, Guerin C, Holland PC, Nalbantoglu J (2007) Interaction of the Coxsackie and adenovirus receptor (CAR) with the cytoskeleton: binding to actin. FEBS Lett 581: 2702-2708
19. Johnson AH, Frierson HF, Zaika A, Powell SM, Roche J, Crowe S, Moskaluk CA, El Rifai W (2005) Expression of tight-junction protein claudin-7 is an early event in gastric tumorigenesis. Am J Pathol 167: 577-584
20. Juttner S, Wissmann C, Jons T, Vieth M, Hertel J, Gretschel S, Schlag PM, Kemmner W, Hocker M (2006) Vascular endothelial growth factor-D and its receptor VEGFR-3: two novel independent prognostic markers in gastric adenocarcinoma. J Clin Oncol 24: 228-240
21. Katoh M (2005) Epithelial-mesenchymal transition in gastric cancer (Review). Int J Oncol 27: 1677-1683
22. Kimura Y, Shiozaki H, Hirao M, Maeno Y, Doki Y, Inoue M, Monden T, Ando-Akatsuka Y, Furuse M, Tsukita S, Monden M (1997) Expression of occludin, tight-junction-associated protein, in human digestive tract. Am J Pathol 151: 45-54
23. Korn WM, Macal M, Christian C, Lacher MD, McMillan A, Rauen KA, Warren RS, Ferrell L (2006) Expression of the coxsackievirus- and adenovirus receptor in gastrointestinal cancer correlates with tumor differentiation. Cancer Gene Ther 13: 792-797
24. Lee SK, Moon J, Park SW, Song SY, Chung JB, Kang JK (2005) Loss of the tight junction protein claudin 4 correlates with histological growth-pattern and differentiation in advanced gastric adenocarcinoma. Oncol Rep 13: 193-199
25. Maehara Y, Kakeji Y, Koga T, Emi Y, Baba H, Akazawa K, Sugimachi K (2002) Therapeutic value of lymph node dissection and the clinical outcome for patients with gastric cancer. Surgery 131: S85-S91
26. Martin TA, Watkins G, Jiang WG (2005) The Coxsackie-adenovirus receptor has elevated expression in human breast cancer. Clin Exp Med 5: 122-128
27. Matsumoto K, Shariat SF, Ayala GE, Rauen KA, Lerner SP (2005) Loss of coxsackie and adenovirus receptor expression is associated with features of aggressive bladder cancer. Urology 66: 441-446
28. Mirza M, Raschperger E, Philipson L, Pettersson RF, Sollerbrant K (2005) The cell surface protein coxsackie- and adenovirus receptor (CAR) directly associates with the ligand-of-Numb Protein-X2 (LNX2). Exp Cell Res 309: 110-120
29. Okegawa T, Li Y, Pong RC, Bergelson JM, Zhou J, Hsieh JT (2000) The dual impact of coxsackie and adenovirus receptor expression on human prostate cancer gene therapy. Cancer Res 60: 5031-5036
30. Okegawa T, Pong RC, Li Y, Bergelson JM, Sagalowsky AI, Hsieh JT (2001) The mechanism of the growth-inhibitory effect of coxsackie and adenovirus receptor (CAR) on human bladder cancer: a functional analysis of car protein structure. Cancer Res 61: 6592-6600
31. Okegawa T, Sayne JR, Nutahara K, Pong RC, Saboorian H, Kabbani W, Higashihara E, Hsieh JT (2007) A histone deacetylase inhibitor enhances adenoviral infection of renal cancer cells. J Urol 177: 1148-1156
32. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108
33. Raschperger E, Thyberg J, Pettersson S, Philipson L, Fuxe J, Pettersson RF (2006) The coxsackie- and adenovirus receptor (CAR) is an in vivo marker for epithelial tight junctions, with a potential role in regulating permeability and tissue homeostasis. Exp Cell Res 312: 1566-1580
34. Rauen KA, Sudilovsky D, Le JL, Chew KL, Hann B, Weinberg V, Schmitt LD, McCormick F (2002) Expression of the coxsackie adenovirus receptor in normal prostate and in primary and metastatic prostate carcinoma: potential relevance to gene therapy. Cancer Res 62: 3812-3818
35. Resnick MB, Gavilanez M, Newton E, Konkin T, Bhattacharya B, Britt DE, Sabo E, Moss SF (2005) Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. Hum Pathol 36: 886-892
36. Sachs MD, Rauen KA, Ramamurthy M, Dodson JL, De Marzo AM, Putzi MJ, Schoenberg MP, Rodriguez R (2002) Integrin alpha(v) and coxsackie adenovirus receptor expression in clinical bladder cancer. Urology 60: 531-536
37. Sanada Y, Oue N, Mitani Y, Yoshida K, Nakayama H, Yasui W (2006) Down-regulation of the claudin-18 gene, identified through serial analysis of gene expression data analysis, in gastric cancer with an intestinal phenotype. J Pathol 208: 633-642
38. Soini Y, Tommola S, Helin H, Martikainen P (2006) Claudins 1, 3, 4 and 5 in gastric carcinoma, loss of claudin expression associates with the diffuse subtype. Virchows Arch 448: 52-58
39. Sollerbrant K, Raschperger E, Mirza M, Engstrom U, Philipson L, Ljungdahl PO, Pettersson RF (2003) The Coxsackievirus and adenovirus receptor (CAR) forms a complex with the PDZ domain-containing protein ligand-of-numb protein-X (LNX). J Biol Chem 278: 7439-7444
40. Wang B, Chen G, Li F, Zhou J, Lu Y, Ma D (2005) Inhibitory effect of coxsackie adenovirus receptor on invasion and metastasis phenotype of ovarian cancer cell line SKOV3. J Huazhong Univ Sci Technolog Med Sci 25: 85-87, 93
41. Wittekind C, Mezer HJ, Bootz F (eds) (2003) TNM Klassifikation maligner Tumoren. 6th edn John Wiley & Sons: New York
42. Wu CM, Lee YS, Wang TH, Lee LY, Kong WH, Chen ES, Wei ML, Liang Y, Hwang TL (2006) Identification of differential gene expression between intestinal and diffuse gastric cancer using cDNA microarray. Oncol Rep 15: 57-64
43. Yasui W, Oue N, Aung PP, Matsumura S, Shutoh M, Nakayama H (2005) Molecular-pathological prognostic factors of gastric cancer: a review. Gastric Cancer 8: 86-94
44. Yonemura Y, Endou Y, Kimura K, Fushida S, Bandou E, Taniguchi K, Kinoshita K, Ninomiya I, Sugiyama K, Heizmann CW, Schafer BW, Sasaki T (2000) Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res 6: 4234-4242
45. Yonemura Y, Ninomiya I, Kaji M, Sugiyama K, Fujimura T, Tsuchihara K, Kawamura T, Miyazaki I, Endou Y, Tanaka M (1995) Decreased E-cadherin expression correlates with poor survival in patients with gastric cancer. Anal Cell Pathol 8: 177-190